Skip to main content
ARTL
NASDAQ Life Sciences

Artelo 10-Q: $4.4M Cash, Going Concern Doubt, $8.8M Nine-Month Cash Burn

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.24
Mkt Cap
$1.205M
52W Low
$1.91
52W High
$179.189
52W Position info
17% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ARTL sits 17% above its 52-week low of $1.91 on light trading volume (0.1× avg).

Summary

Artelo's Q3 2026 10-Q shows $4.4 million of cash against an $8.8 million nine-month operating burn, with management repeating substantial doubt about going-concern status and flagging that its public float value sits near Nasdaq's $1 million minimum.


Key Events · Earnings and Guidance · ARTL

  • Going Concern Doubt Reiterated

    The 10-Q states conditions raise substantial doubt about the company's ability to continue as a going concern within one year after the financial statements are issued.

  • Cash of $4.4M vs $8.8M Burn

    Cash and cash equivalents were $4,437 thousand at September 30, 2026 versus $600 thousand at December 31, 2025, while net cash used in operating activities was $8,849 thousand for the nine months.

  • Financings Funded the Period

    Net proceeds from common share issuance were $13,069 thousand, including $10,033 thousand net from the March 2026 private placement and $3,037 thousand net from 432,062 ATM shares.

  • Nasdaq Public Float Near Minimum

    A new risk factor discloses the market value of publicly held shares was approximately $2 million as of November 11, 2026, close to the $1 million continued-listing minimum.


Analysis · ARTL · Life Sciences

Artelo closed September 30, 2026 with $4.4 million in cash after raising roughly $13.1 million net from share sales in the first nine months, yet the report repeats substantial doubt about its ability to continue as a going concern within a year. The nine-month operating cash burn of $8.8 million is more than double the $4.4 million cash balance, so another raise is required — and the company's own new risk factor notes the market value of publicly held shares was only about $2 million as of November 11, 2026, close to Nasdaq's $1 million minimum. Funding for the period came from the March 2026 private placement ($11.0 million gross, $10.0 million net) and the ATM (432,062 shares for $3.0 million net), but the equity line and shelf are constrained by the one-third-of-public-float limit. Meanwhile, the Craft Capital FINRA arbitration, seeking an $880,000 success fee plus warrants valued at $880,000, remains unresolved with no liability recorded.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARTL was trading at $2.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $1.91 to $179.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARTL - Latest Insights

ARTL
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.19
Real-time Price: $2.24 info
Change: -$0.9501 (-30%) info
Market Cap: $1.205M info
ARTL
Sep 23, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.84
Real-time Price: $2.24 info
Change: -$5.60 (-71%) info
Market Cap: $1.205M info
ARTL
Sep 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $2.24 info
Change: -$2.78 (-55%) info
Market Cap: $1.205M info
ARTL
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.658
Real-time Price: $2.24 info
Change: Reverse Stock Split info
Market Cap: $1.205M info
ARTL
Aug 27, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.6899
Real-time Price: $2.24 info
Change: Reverse Stock Split info
Market Cap: $1.205M info